US 7358260
Quinuclidine derivatives and medicinal compositions containing the same
granted A61KA61K31/439A61K31/4745
Quick answer
US patent 7358260 (Quinuclidine derivatives and medicinal compositions containing the same) held by Laboratories Almirall, S.A. expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Laboratories Almirall, S.A.
- Grant date
- Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/439, A61K31/4745, A61K31/56, A61K45/06